PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för dotarizine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

26 hits

Bibliografisk träff 2011-01-01

Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.

Onal MB, Solmaz I, Civelek E, Kircelli A, Tehli O, Izci Y, Erdogan E, Gonul E.

Acta Neurochir Suppl · comparative study; journal article · DOI 10.1007/978-3-7091-0356-2_11

Bibliografisk träff 2005-09-01

Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells.

Gallego-Sandín S, Novalbos J, Rosado A, Cano-Abad MF, Arias E, Abad-Santos F, García AG.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2005.06.044

Bibliografisk träff 2003-11-01

Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells.

Ruiz-Nuño A, Mayorgas I, Hernández-Guijo JM, Olivares R, García AG, Gandía L.

Eur J Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2003.09.013

Bibliografisk träff 2001-01-01

Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility.

Ruiz-Nuño A, Villarroya M, Cano-Abad M, Rosado A, Balfagón G, López MG, García AG.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(00)00897-9

Bibliografisk träff 2000-08-01

Ba(2+)-induced chromaffin cell death: cytoprotection by Ca(2+) channel antagonists.

Cano-Abad MF, García AG, Sánchez-García P, López MG.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(00)00464-7

Bibliografisk träff 2000-04-01

Regional differences of cerebrovascular reactivity effected by calcium channel blocker - dotarizine.

Kuridze N, Czernicki Z, Jarus-Dziedzic K, Jurkiewicz J, Cervos-Navarro J.

J Neurol Sci · journal article · DOI 10.1016/s0022-510x(00)00275-6

Bibliografisk träff 2000-03-01

Vasostabilizing effect of Dotarizine (Ca(2+)-channel blocker) on cerebrovascular reactivity in rabbits.

Kuridze N, Czernicki Z, Jarus-Dziedzic K, Jurkiewicz J, Cervos-Navarro J.

Neurol Res · journal article · DOI 10.1080/01616412.2000.11740664

Bibliografisk träff 2000-01-01

Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.

Petkov VD, Konstantinova E, Petkov VV, Belcheva S, Kehayov R, Vaglenova J.

Acta Physiol Pharmacol Bulg · research support, non-u.s. gov't; journal article

Bibliografisk träff 1999-10-01

Novel antimigraineur dotarizine releases Ca2+ from caffeine-sensitive Ca2+ stores of chromaffin cells.

Novalbos J, Abad-Santos F, Zapater P, Alvarez J, Alonso MT, Montero M, García AG.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/sj.bjp.0702853

Bibliografisk träff 1999-08-01

Cerebrovascular effects of dotarizine, a piperazine derivative, in the goat. An in vivo and in vitro complementary study.

Torregrosa G, Barberá MD, Ortí M, Centeno JM, Salom JB, Alborch E.

Arzneimittelforschung · research support, non-u.s. gov't; journal article · DOI 10.1055/s-0031-1300480

Bibliografisk träff 1999-02-01

Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+.

Novalbos J, Abad-Santos F, Zapater P, Cano-Abad MF, Moradiellos J, Sánchez-García P, García AG.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(98)00916-9

Bibliografisk träff 1999-01-01

Effect of oral administration of dotarizine on cerebrovasculature subjected to constriction followed by dilatation in rabbits.

Jarus-Dziedzic K, Czernicki Z, Cervos-Navarro J, Jurkiewicz J.

Acta Neurochir (Wien) · journal article · DOI 10.1007/s007010050420

Bibliografisk träff 1998-01-01

Behavioral changes as a result of dotarizine or flunarizine influence on dopaminergic neurotransmission in the striatum.

Petkov VD, Petkova B.

Acta Physiol Pharmacol Bulg · journal article

Bibliografisk träff 1998-01-01

Does nitric oxide participate in the mechanism of action of dotarizine?

Petkov VD, Belcheva S, Konstantinova E, Petkov VV.

Acta Physiol Pharmacol Bulg · comparative study; journal article

Bibliografisk träff 1998-01-01

[Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo)].

Perelló E, Esteller E, Colls A, Magriñá C, Massegur H, Lluansí J, Casamitjana JF, Lao X, Roca-Ribas F, Miró N, Prades J, Herrero E, Molá O, Torres J, Márquez M, Ortiz JA.

An Otorrinolaringol Ibero Am · comparative study; clinical trial; randomized controlled trial; journal article; english abstract

Bibliografisk träff 1998-01-01

The effect of Dotarizine--(Ca2+ channel blocker)--on vascular reactivity and ultrastructure of cerebral capillaries in animals subjected to anoxia.

Kuridze N, Gajkowska B, Czernicki Z, Jurkiewicz J, Cervos-Navarro J.

Folia Neuropathol · journal article

Bibliografisk träff 1997-08-01

Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.

Montiel C, Herrero CJ, García-Palomero E, Renart J, García AG, Lomax RB.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(97)01073-x

Bibliografisk träff 1997-06-01

Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.

Farré M, Roset PN, Llorente M, Márquez M, Albet C, Pérez JA, Herrero E, Ortíz JA.

Methods Find Exp Clin Pharmacol · clinical trial; randomized controlled trial; journal article

Bibliografisk träff 1997-01-01

Effect of dotarizine on K(+)-stimulated [3H]-serotonin and [3H]-acetylcholine release from rat hippocampus.

Hadjiivanova C, Petkov VD, Maslarov D, Totev A, Panova Y, Belcheva I.

Gen Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0306-3623(96)00177-2

Bibliografisk träff 1997-01-01

The effect of Dotarizine (Ca2+ channel blocker) on cerebral vessel reactivity in animals subjected to hyperventilation and anoxia.

Czernicki Z, Kuridze N, Jurkiewicz J, Cervós-Navarro J.

Acta Neurochir Suppl · journal article · DOI 10.1007/978-3-7091-6837-0_64

Bibliografisk träff 1996-11-01

Effects of the calcium channel blockers Dotarizine and Flunarizine on cerebrovascular reactivity.

Czernicki Z, Jurkiewicz J, Bojanowski K, Piechnik S, Cervos-Navarro J.

J Neurol Sci · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-510x(96)00114-1

Bibliografisk träff 1995-12-01

Anxiolytic effects of dotarizine, a possible antimigraine drug.

Petkov VD, Belcheva S, Konstantinova E.

Methods Find Exp Clin Pharmacol · journal article

Bibliografisk träff 1995-01-01

Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.

Villarroya M, Gandía L, Lara B, Albillos A, López MG, García AG.

Br J Pharmacol · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/j.1476-5381.1995.tb13236.x

Bibliografisk träff 1995-01-01

Effect of dotarizine on CO2-dependent cerebrovascular reactivity.

Chomicki J, Jurkiewicz J, Zabolotny W, Czernicki Z, Cervos-Navarro J.

Acta Neurochir (Wien) · journal article · DOI 10.1007/bf01410624

Bibliografisk träff 1994-03-01

Effects of dotarizine on peripheral and pulmonary circulation and cardiac dynamics in dogs.

Cartheuser CF, Brasó A, Sacristán A, Ortiz JA.

Pharmacology · comparative study; journal article · DOI 10.1159/000139178

Bibliografisk träff 1994-01-01

Behavioral effects of the Ca2+/5-HT antagonist dotarizine.

Petkov VD, Belcheva S, Konstantinova E, Vaglenova J, Petkov VV.

Acta Physiol Pharmacol Bulg · research support, non-u.s. gov't; journal article